Why might a doctor suggest a compounded medicine?

What does compounding mean?

Compounding starts with a person’s need for a specially prepared medicine. A doctor or pharmacist can make it, as can a specialist medicine-making business. This differs from handing over a finished drug-company product.

These specialist businesses can choose to register with the US Food and Drug Administration, called FDA. Registration records the business with that agency; it does not mean FDA approves it. This was the position checked September 26, 2026.

For example, a dye allergy may mean preparing medicine without that dye; a patient who cannot swallow tablets may need a different form.

• What change is being made?
• What need of mine does the change address?
• Who would prepare the medicine?

What review has it had?

A compounded medicine has no FDA approval. For a compounded medicine, FDA checks none of these before sale: how well it was made, its safety and whether it works. This was the position checked September 26, 2026.

A medicine-making business can be registered with FDA while its medicines still lack approval, as of September 26, 2026.

• How would the prescriber explain the benefit and the uncertainty?
• Which pharmacy board holds the licence?
• What information would come with the medicine?

Why is a lower price not the whole answer?

Federal law limits pharmacies and doctors making near copies of medicines already on sale too often or in excessive amounts. Specialist medicine-making businesses face a separate ban on near copies of approved drugs. These were the rules checked September 26, 2026.

Changing a preparation for a patient identified by name may allow a pharmacy or doctor an exception to the copying limit. The prescriber must compare it with the ready-made medicine and decide that the change is important for this particular patient. A cheaper price does not qualify as that change, under the September 26, 2026 rules. Ask the pharmacist which other rules the preparation must meet.

When checked September 26, 2026, the national shortage list kept by FDA had no semaglutide injection or tirzepatide injection entry.

So a national shortage could no longer be the reason for making copies of those injections. Ask the pharmacist what rule permits the exact preparation being proposed, as of September 26, 2026.

• What need of mine cannot be met with an approved medicine?
• What rule allows this exact preparation?
• How has the reason been recorded for me?